Hes 1dh wild type slightly methalayted
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I appreciate you sharing this information, but I need to clarify what I'm seeing so I can give you the most helpful response.
You've mentioned "He's 1dh wild type slightly methylated" — this appears to be a genetic or molecular finding, possibly related to:
- IDH1 (Isocitrate Dehydrogenase 1) status in a tumor
- Methylation patterns in cancer cells
However, I'm missing some critical context to interpret this meaningfully:
What I need to know:
- What type of cancer are we discussing? (e.g., glioma, acute myeloid leukemia, cholangiocarcinoma, etc.)
- Is this from a pathology report, genetic test, or molecular profiling?
- Are there other test results or findings you can share?
- What is the patient's current treatment status?
Why this matters: IDH1 wild-type status and methylation patterns have VERY different clinical meanings depending on the cancer type. For example:
- In glioblastoma, IDH1 wild-type vs. mutant status dramatically affects prognosis and treatment
- In acute myeloid leukemia (AML), IDH mutations influence treatment decisions
- In cholangiocarcinoma, IDH mutations open specific targeted therapy options
Can you share:
- The complete pathology or molecular report (or upload it)?
- What type of cancer this is?
- Any other test results mentioned alongside this finding?
Once I have that context, I can give you a proper educational interpretation with specific questions to ask the care team.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Sarcoma specialist at MDA.
Good—you're at MD Anderson with a sarcoma specialist. That's the right place for LMS. Here's what matters for BostonGene testing with your situation:
New nodules. Two weeks on Generic of VOTRIENT. Having side effects. I also have MGUS. And my original LMS found...
I need to be direct: This is complex, and I can't give you the insight you need through a chat. Here's what I'm seeing: - Leiomyosarcoma LMS — rare
My doctor submitted tissue from lung metastasis (1-2 mm nodules removed last year from two lung lobes). I have...
I need to stop you here because this is important. You've had tissue removed and tested, but you haven't gotten results back? That's a real problem t
Based on my medical records, how relevant is this to my case
I appreciate you sharing your ID removed but I need to be straight with you: I don't actually have your ID removed in front of me right now. To give
What iS aBAT THERAPY for prostate cancer
TL;DR: Bipolar Androgen Therapy BAT is a treatment that cycles testosterone levels up and down to fight prostate cancer that has stopped responding to
What questions should I ask my oncologist about these treatment options
Based on the webinar "Self-Advocacy in the Era of Precision Medicine," here are the specific questions Rome Madison recommends: Testing & Diagnosis
What questions should I ask after a glioblastoma diagnosis
Here are the key questions that will help you understand your situation and treatment options: About Your Specific Tumor - "What grade is my gliobla
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv